[go: up one dir, main page]

CN114230681A - A kind of extracellular polysaccharide extract, extracellular polysaccharide and application thereof - Google Patents

A kind of extracellular polysaccharide extract, extracellular polysaccharide and application thereof Download PDF

Info

Publication number
CN114230681A
CN114230681A CN202111422635.7A CN202111422635A CN114230681A CN 114230681 A CN114230681 A CN 114230681A CN 202111422635 A CN202111422635 A CN 202111422635A CN 114230681 A CN114230681 A CN 114230681A
Authority
CN
China
Prior art keywords
exopolysaccharide
column
desalting
extract
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111422635.7A
Other languages
Chinese (zh)
Inventor
耿丽丽
王美玲
张�杰
束长龙
王泽宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Plant Protection of CAAS
Original Assignee
Institute of Plant Protection of CAAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Plant Protection of CAAS filed Critical Institute of Plant Protection of CAAS
Priority to CN202111422635.7A priority Critical patent/CN114230681A/en
Publication of CN114230681A publication Critical patent/CN114230681A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0087Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/14Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
    • A01N43/16Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003General processes for their isolation or fractionation, e.g. purification or extraction from biomass

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Sustainable Development (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Emergency Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides an extracellular polysaccharide extract, an extracellular polysaccharide and application thereof. The extract is extracted from bacillus thuringiensis, mainly comprises extracellular polysaccharide and can induce plants to generate system disease resistance to plant fungal diseases.

Description

Extracellular polysaccharide extract, extracellular polysaccharide and application thereof
Technical Field
The invention provides an extracellular polysaccharide extract, in particular to an extracellular polysaccharide extract extracted from bacillus thuringiensis, which can induce rape to generate disease resistance.
Background
The extracellular polysaccharide of bacteria is a polysaccharide mixture which is synthesized by bacteria in the process of growth and metabolism and secreted to the extracellular part, and is a long-chain high-molecular polymer which is polymerized by the same or different monosaccharide units through glycosidic bonds. Exopolysaccharides (EPSs) produced by bacteria exist mainly in two forms, Capsular Polysaccharides (CPS) tightly bound to the cell surface and mucopolysaccharides ("Slime"), also called Free Exopolysaccharides (EPS), secreted extracellularly as mucus, with a small amount of Free exopolysaccharides being the main constituent of the biofilm as a water-soluble matrix. The way of distinguishing capsular polysaccharide from free exopolysaccharide is not absolute by the tight degree of exopolysaccharide binding with cells, and a small amount of capsular polysaccharide is not stably connected with cell surface phospholipid and can be released into a culture medium to become free exopolysaccharide, and the free exopolysaccharide can become a component of capsular polysaccharide due to the close contact with cells. The distribution of these extracellular polymeric substances is influenced by the natural growth environment of the cells, such as the chemical properties of the culture solution, the abundance of nutrients, the growth period of the cells, and the like.
The presence of the outermost capsular polysaccharide or extracellular free polysaccharide of bacteria results in an additional barrier between the cell membrane and the external environment. The diversity of chemical compositions of polysaccharides, such as monosaccharide compositions, results in differences in the structures of different species of the same flora, and the diversity of biological functions of the polysaccharides. In addition, some physicochemical properties of the exopolysaccharide, such as stability, consistency, flocculation, suspension, film forming property, water holding capacity and the like, make the exopolysaccharide widely applied to different industrial industries, such as food industry, cosmetic industry, pharmaceutical industry, petroleum industry, mining industry and the like.
Except for a few gram-positive bacteria, most bacterial exopolysaccharides are transported intracellularly for synthesis. Its biosynthesis is carried out in stages: first, sugar nucleotides are assembled into "chemical" oligosaccharide repeat units under the action of glycosyltransferases; the chemical repeat units are subsequently polymerized in the presence of a polymerase to form "biological" repeat units such as macromolecular polysaccharides. A large number of sugar residues make up the backbone of the polysaccharide and in addition include some non-sugar substituents, such as acetate, pyruvate, succinate, phosphate, and the like. The composition, chemical and physical properties of extracellular polysaccharides of bacteria determine the main conformation of the polysaccharides, and these properties are quite different from one bacterial species to another. Different types of capsular polysaccharides can be produced by the same species of bacterial flora. Thus, different biological functions are gradually discovered, and the extracellular polysaccharide can be hidden on the surface of bacteria under natural conditions, can be used as a bonding agent to interact with other bacteria surface or lower substances, can protect the bacteria against the stress of the external environment, can be used as a matrix for bacteria to aggregate at the rhizosphere to form a biofilm and maintain the stability of the biofilm, and can be used as a signal molecule for the bacteria to exchange with the outside. In a severe growth environment, bacteria can utilize extracellular polysaccharide secreted by the bacteria as a carbon source. The production of extracellular polysaccharide is low, so that the market application of the polysaccharide is limited.
In recent years, with the rapid development of chemistry, molecular biology and imaging technology, the potential functions of extracellular polysaccharides of bacteria still need to be explored.
Disclosure of Invention
The invention provides an exopolysaccharide extract, which is obtained by the following steps:
firstly), adjusting the pH value of fermentation liquor of the Bacillus thuringiensis IPPBiotSR045 to 8-9, then carrying out first centrifugation, and collecting first supernatant after the first centrifugation;
secondly) adding trichloroacetic acid or trichloroacetic acid water solution into the first supernatant, thereby treating the first supernatant with trichloroacetic acid to obtain a first treatment solution, then carrying out second centrifugation, and collecting a second supernatant after the second centrifugation;
and thirdly) adjusting the pH value of the second supernatant to 6-7, adding ethanol into the second supernatant to obtain a second treatment solution, precipitating the second treatment solution, then carrying out third centrifugation, and collecting precipitate after the third centrifugation, wherein the precipitate is the wet crude extracellular polysaccharide extract.
In a specific embodiment, the method further comprises the steps of removing residual protein, desalting, ion exchange chromatography and gel filtration chromatography of the crude exopolysaccharide extract in sequence.
In a specific embodiment, the residual protein is removed using proteinase K; using HiPrepTM26/10Desalting the crude extracellular polysaccharide extract with residual protein removed with Desalting column to obtain desalted chromatography liquid; purifying the desalted chromatographic solution by using a HiTrap Q HP Column anion exchange Column to obtain an ion chromatographic solution;purifying the ion chromatography liquid by using a HiLoad 26/600 Sephacryl S-100column gel filtration layer column to obtain gel chromatography liquid with a plurality of hole sites; mixing the gel chromatography liquid containing the extracellular polysaccharide hole sites, and concentrating by using a freeze drying instrument to obtain a wet pure extracellular polysaccharide extract; or drying into powder with freeze drying instrument to obtain dried pure exopolysaccharide extract.
In one embodiment, HiPrep is utilizedTM26/10 desaling Desalting column for crude exopolysaccharide extract with residual protein removed comprises the following steps:
1) centrifuging the crude extracellular polysaccharide extract water solution with residual protein removed at 10000r/min for 20min to remove impurities;
2) subjecting the desalting column HiPrepTM26/10 desaling loading protein purification system
Figure BDA0003377046150000021
In the method, the ultra-pure water is used for cleaning the HiPrep containing desalting columnTM26/10 desaling-containing protein purification system
Figure BDA0003377046150000022
3) Filtering the crude extracellular polysaccharide extract water solution with residual protein removed by using a bacterial membrane to obtain a filtered extract water solution, and loading 7mL of the filtered extract water solution to a desalting column at the flow rate of 10mL/min each time;
4) according to UV490Respectively starting and ending the peak value and the peak position of the salt peak, and collecting samples flowing out of the desalting column to obtain a desalting chromatographic solution;
the purification of the desalted chromatography liquid by using a HiTrap Q HP Column anion exchange Column comprises the following steps:
I) installing the anion exchange column in a protein purification system
Figure BDA0003377046150000031
In addition, the ultrapure water is utilized to clean the protein purification system
Figure BDA0003377046150000032
At the same time, 2mol/L sodium chloride aqueous solution is used for balancing the anion exchange column;
II) after the concentration of the extracellular polysaccharide in the desalted chromatographic solution is 10-15mg/mL, loading the desalted chromatographic solution to an anion exchange column by using an S1 loading pump, wherein the loading amount is 15-20mL each time, the flow rate is 2.0mL/min, and meanwhile, manually collecting by using a 96-hole deep-hole plate, namely 1.7 mL/tube;
III) after the sample loading is finished, washing the anion exchange column by ultrapure water with 5 times of the column volume of the anion exchange column;
IV) carrying out linear elution with the concentration of 0-100% by using 2mol/L sodium chloride aqueous solution for 20min at the flow rate of 5mL/min to obtain an eluent;
v) detecting the hole site of the eluent containing the exopolysaccharide by using a phenol-sulfuric acid method, mixing the eluent containing the hole site of the exopolysaccharide, and concentrating by using a freeze dryer to obtain an ion chromatography liquid;
the purification of the ion chromatography liquid by using HiLoad 26/600 Sephacryl S-100column gel filtration chromatography comprises the following steps:
A) installing the gel filtration chromatography column in a protein purification system
Figure BDA0003377046150000033
In the above, the protein purification system was washed with 0.15mol/L aqueous sodium chloride solution
Figure BDA0003377046150000034
And a gel filtration chromatography column;
B) taking 5mL of ion chromatography liquid each time, manually loading the sample to a gel filtration chromatography column, immediately collecting a sample flowing out of the gel filtration chromatography column by using a 96-well plate, wherein the flow rate of a system is 0.5mL/min, 0.5mL is collected in each hole, and stopping collecting 180mL in total to obtain gel chromatography liquid;
C) detecting the hole position of the gel chromatographic solution containing the extracellular polysaccharide by using a phenol-sulfuric acid method, and mixing the gel chromatographic solution containing the hole position of the extracellular polysaccharide; concentrating with freeze drying instrument to obtain wet pure extracellular polysaccharide extract; or drying into powder with freeze drying instrument to obtain dried pure exopolysaccharide extract.
In a specific embodiment, in step 2), the mass/volume content of the trichloroacetic acid and the first supernatant is between 0.4% and 0.5%.
In a specific embodiment, in step 3), the volume of ethanol added to the second supernatant is 3 to 3.5 times the volume of the second supernatant.
In one embodiment, in step 2), the first treatment liquid is left at a temperature of 25 to 35 ℃ for 1.5 to 3 hours.
In one embodiment, in step 3), the second treatment solution is left at 2 to 8 ℃ for 12 to 20 hours.
In a specific embodiment, the centrifugation speed of the first centrifugation, the second centrifugation, and the third centrifugation is independently 6000 to 8000r/min, the centrifugation temperature is independently 3 to 10 ℃, and the centrifugation time is independently 30 to 40 min.
In one embodiment, the culture medium for culturing the bacillus thuringiensis is one of an LB culture medium, a glucose-producing culture medium with glucose as a substrate, and a sucrose-producing culture medium with sucrose as a substrate.
In one embodiment, the precipitate is freeze-dried to obtain a dry crude exopolysaccharide extract.
The second invention provides an exopolysaccharide, wherein the Mw is 66.2kDa, the Mn is 42.7kDa, the Mz is 87.6kDa and the polydispersity is 1.55, the exopolysaccharide is composed of mannose, glucuronic acid, glucose and galactose, wherein the relative molar ratio of the mannose, the glucuronic acid, the glucose and the galactose is 55.77: 5.67: 3.70: 1. the relative molar ratio of the monosaccharides can be converted into the mass percentage content, and after the conversion, the mass of the exopolysaccharide is taken as 100%, the content of mannose is 83.77%, the content of glucuronic acid is 9.18%, the content of glucose is 5.56%, and the content of galactose is 1.49%.
The third invention provides the application of the extract or the exopolysaccharide in the second invention in inducing plant disease resistance.
In a specific embodiment, the plant is canola.
In one embodiment, the disease resistance is against a disease caused by sclerotinia sclerotiorum.
The invention has the beneficial effects that:
it is found for the first time that exopolysaccharides produced by Bt can induce plants to produce systemic disease resistance to plant fungal diseases, and the disease resistance is generated by the activation of jasmonic acid and ethylene signal pathways.
Drawings
FIG. 1 shows OD of extracellular polysaccharide-containing eluents at different pore sites after anion exchange chromatography490The value is obtained.
FIG. 2 shows OD of extracellular polysaccharide-containing eluents at different pore sites after gel filtration chromatography490The value is obtained.
Fig. 3 shows the full wavelength scan results of pure exopolysaccharides purified from IPPBiotSR045 strain.
Fig. 4 shows the results of ion chromatography detection of standard monosaccharides and exopolysaccharides purified from IPPBiotSR045 strain. Wherein the upper curve is the ion chromatography result of a standard monosaccharide; the lower curve is the ion chromatography result of exopolysaccharides purified from IPPBiotSR045 strain.
Fig. 5 shows exopolysaccharide-induced disease resistance of canola systems purified from IPPBiotSR045 strain.
FIG. 6 shows the transcription of jasmonic acid signal pathway related gene BnHEL.
FIG. 7 shows the transcription of jasmonic acid/ethylene signal pathway related gene BnPDFF 1.2.
FIG. 8 shows the transcription of the salicylic acid signal pathway related gene BnWRKY 70.
Detailed Description
The present invention is further illustrated by the following examples, which are intended to be purely exemplary of the invention and are not to be construed as limiting the invention in any way.
The reagents in the examples of the present invention were all commercially available unless otherwise specified.
Peptone, yeast extract, PDA, MS medium solid powder were purchased from Beijing Bingda Biotech Ltd.
Glucose, sucrose, aniline blue, bengal red were purchased from sigma.
Other biochemical reagents are all commercially available domestic or imported analytical pure or electrophoretic pure chemical reagents.
Liquid LB medium: 10.0g peptone, 5.0g yeast extract, 10.0g sodium chloride, 1.0L volume by volume with distilled water, and sterilizing at 121 deg.C for 20 min.
A sugar production culture medium using glucose as a substrate: 10.0g glucose, 5.0g yeast extract, and distilled water with volume value of 1.0L, sterilizing at 115 deg.C for 30 min.
Sugar production medium with sucrose as substrate: 20.0g sucrose, 5.0g yeast extract, and distilled water with volume value of 1.0L, sterilizing at 115 deg.C for 30 min.
Aniline blue selective medium: 0.05g/L aniline blue solid and 15.0g/L agar powder are respectively added into the two sugar production culture mediums.
PDA solid medium: 39.0g PDA powder was dissolved in 1.0L distilled water, and sterilized with distilled water at 115 ℃ for 15min to give a volume value of 1.0L.
Solid culture medium of Bengal red: 0.5 wt% of peptone, 1 wt% of sodium chloride, 1 wt% of glucose, 0.1 wt% of monopotassium phosphate, 0.05 wt% of magnesium sulfate, 2 wt% of agar, 3mL of 1 wt% of Bengal mother liquor, 1.0L of volume value by using distilled water, and sterilizing for 15min at 115 ℃. Before use, streptomycin is coated by 50 mug/mL according to requirements.
MS culture medium: the MS culture medium solid powder is subjected to volumetric value of 1.0L by using distilled water and sterilized for 15min at 121 ℃.
Extracting and quantifying reagent for extracellular polysaccharide:
1mol/L sodium hydroxide: 4.0g of sodium hydroxide was dissolved in 100mL of sterile distilled water and stored at room temperature.
2mol/L hydrochloric acid: 500mL of sterile distilled water was added to 100mL of concentrated hydrochloric acid, and the mixture was stored at room temperature.
95% ethanol: 950mL of absolute ethanol was added with 50mL of sterile distilled water and stored at room temperature.
80% phenol: 80.0g of phenol was dissolved in 50mL of sterile distilled water, and the volume was adjusted to 100mL with sterile distilled water, and the solution was stored at 4 ℃ in the dark.
The main apparatus comprises: a full-automatic moist heat sterilizer, SANYO, Japan, model MLS-3780/MAC 350P; superclean bench, Beijing Hardong corporation, model DL-CJ-2N; a constant temperature incubator, Shanghai laboratory Instrument Master, model DHP 120; temperature controlled shaker, model MAXQ5000, manufactured by Thermo corporation, USA; a bench centrifuge, eppendorf, germany, model 5415C; high speed centrifuge, Beckman, USA, model Avanti J-26 xp; freeze dryer VirTis, usa.
The cabbage type rape (Brassica campestris L.) is Shanghai green.
The rape planting site is as follows: greenhouse of pilot plant base in corridor of institute of plant protection of Chinese academy of agricultural sciences. The planting mode is as follows: the rape seeds are subjected to surface disinfection by using 75% alcohol, 5% sodium hypochlorite and sterile water in sequence, and are uniformly sowed on an MS (Murashige and Skoog, MS) solid culture medium plate. After about 10 days, the seedlings were transplanted into seedling pots (diameter 6.0cm, depth 10.0cm), and planting soil included nutrient soil and vermiculite (ratio 2: 1). The culture conditions are as follows: the illumination time is 14h, and the illumination intensity is 7,000 Lux; the dark time was 10 h. Growth temperature: about 22 deg.c.
The IPPBiotSR045 strain is preserved in the China general microbiological culture Collection center of China Committee for culture Collection of microorganisms with the preservation number of CGMCC No.13302, the preservation date of 2016, 11 and 15 days, and the preservation addresses of: the institute of microbiology, national academy of sciences No.3, Xilu No.1, Beijing, Chaoyang, Beijing. The system is classified as Bacillus thuringiensis (Bacillus thuringiensis).
Example 1
1. Extraction of crude exopolysaccharides
(1) Inoculating 10 mu L of glycerol strain of Bacillus thuringiensis IPPBiotSR045 into 5mL of liquid LB culture medium, and activating at 30 ℃ and 220r/min for 10h to obtain activated bacteria liquid;
(2) transferring the activated bacterium liquid into 100mL of liquid LB culture medium by the inoculation amount of 1%, and culturing in a 500mL triangular flask for 30h to obtain fermentation liquid;
(3) collecting the obtained fermentation liquor, adjusting the pH of the fermentation liquor to 8.5, 4 ℃ and 7000r/min by using 1mol/L NaOH, centrifuging for 30min, and collecting a first supernatant;
(4) adding 1/10 volume of 5 wt% trichloroacetic acid aqueous solution into the first supernatant, and denaturing the protein at 25 deg.C for 2 hr;
(5) centrifuging at 4 deg.C for 30min at 7000r/min, collecting second supernatant, and adjusting pH to 6.5;
(6) adding 3 times volume of absolute ethyl alcohol to precipitate for 12 hours in a refrigerator at 4 ℃ overnight to generate brown precipitate;
(7) centrifuging at 4 deg.C for 30min at 7000r/min, discarding supernatant, and freeze drying brown precipitate to obtain crude exopolysaccharide powder.
2. Quantification of exopolysaccharides
2.1 preparation of Standard Curve
Firstly, preparing a glucose mother solution: 0.1g of glucose is dissolved in 250mL of sterile distilled water and stirred evenly to prepare a glucose mother liquor.
Then glucose mother liquor is utilized to prepare glucose standard liquor with different concentration gradients, then 0.1mL of 98% concentrated sulfuric acid and 0.5mL of 6 wt% phenol aqueous solution are respectively added into the glucose standard liquor with different concentration gradients, and sterile distilled water is added to make up to a system of 0.8 mL. Slowly mixing, cooling, standing at room temperature for 20min, measuring light absorption value at 490nm in an enzyme labeling plate at 200 μ L, replacing sample with sterile distilled water as blank control, and repeating three times for each treatment group to draw a standard curve.
2.2 phenol-sulfuric acid method of quantitation
Diluting with different gradients (to make OD)490nmValue between 0.2 and 1.0), adding 0.1mL of concentrated sulfuric acid and 0.5mL of 6 wt% of phenol aqueous solution into a centrifuge tube, then supplementing to 0.8mL of system with sterile distilled water, mixing uniformly, cooling, standing at room temperature for 20min, taking 200 mu L of the mixture in an enzyme label plate, measuring the light absorption value at 490nm, and calculating the content of the extracellular polysaccharide in the sample according to a standard curve drawn by 2.1.
The amount of the exopolysaccharide in the crude exopolysaccharide extracted from the IPPBiotSR045 strain is 210mg/L of bacterial liquid.
Example 2
Crude exopolysaccharide extraction was the same as in subsection 1 of example 1, except that:
in the step (2), respectively transferring the activated bacterium liquid into 100mL of liquid culture medium of a sugar production culture medium taking glucose as a substrate by using the inoculation amount of 1%, and culturing in a 500mL triangular flask for 30h to obtain fermentation liquid;
in the step (3), respectively collecting the obtained fermentation liquor, adjusting the pH of the fermentation liquor to 8, 3 ℃ and 6000r/min by using 1mol/L NaOH, centrifuging for 40min, and collecting a first supernatant;
in the step (4), 1/10 volumes of 4 wt% trichloroacetic acid aqueous solution is added into the first supernatant, and the protein is denatured for 3 hours at 35 ℃;
centrifuging at 3 deg.C and 8000r/min for 30min in step (5), collecting second supernatant, and adjusting pH to 6;
in the step (6), adding 3 times of volume of absolute ethyl alcohol to precipitate for 16 hours at 2 ℃ in a refrigerator;
and (7) centrifuging at 3 ℃ and 6000r/min for 40min, discarding supernatant, and freeze-drying the precipitate to obtain crude exopolysaccharide powder.
The amount of the exopolysaccharide in the crude exopolysaccharide extracted from the IPPBiotSR045 strain is 200mg/L of bacterial liquid.
Example 3
Crude exopolysaccharide extraction was the same as in subsection 1 of example 1, except that:
in the step (2), respectively transferring the activated bacterium liquid into 100mL of liquid culture medium of a sugar production culture medium taking sucrose as a substrate by using the inoculation amount of 1%, and culturing in a 500mL triangular flask for 30h to obtain fermentation liquid;
in the step (3), respectively collecting the obtained fermentation liquor, adjusting the pH of the fermentation liquor to 9, 10 ℃ and 8000r/min by using 1mol/L NaOH, centrifuging for 30min, and collecting a first supernatant;
in the step (4), 1/10 volumes of 5 wt% trichloroacetic acid aqueous solution is added into the first supernatant, and the protein is denatured at 25 ℃ for 1.5 hours;
centrifuging at 3 deg.C and 6000r/min for 40min in step (5), collecting second supernatant, and adjusting pH to 7;
in the step (6), adding 3 times of volume of absolute ethyl alcohol to precipitate for 20 hours at 8 ℃ in a refrigerator;
in the step (7), centrifuging at 10 ℃ and 8000r/min for 30min, discarding supernatant, and freeze-drying precipitate to obtain crude exopolysaccharide powder.
The amount of the exopolysaccharide in the crude exopolysaccharide extracted from the IPPBiotSR045 strain is 200mg/L of bacterial liquid.
Example 4
Extracellular polysaccharide was extracted from a bacterial solution obtained by culturing IPPBiotSR045 strain in 7L LB medium.
Extraction and quantification of crude exopolysaccharide as in example 1, the powder of crude exopolysaccharide was then dissolved in 50mL of ultra pure water.
Purification of exopolysaccharides
1.1 digestion of residual proteins
(1) Quantifying residual protein in the sample by using a BCA total protein quantification kit (Thermo);
(2) adding protease K with total residual protein mass of 1/10;
(3) carrying out enzymolysis for 2h in a water bath at 50 ℃, and analyzing whether protein is completely removed by SDS-PAGE;
(4) if the residual protein is not completely removed, adding protease K again for treatment until the protein removes the bacillus; and after the protein is completely removed, carrying out boiling water bath treatment for 15min, and inactivating the protease to obtain a crude extracellular polysaccharide solution with the protein removed for later purification.
1.2 desalination
The desalting column is HiPrepTM26/10 desaling, the purification procedure for deproteinized crude exopolysaccharide solution is as follows:
(1) centrifuging the crude extracellular polysaccharide solution with protein removed at 10000r/min for 20min to remove impurities;
(2) subjecting the desalting column HiPrepTM26/10 desaling loading protein purification system
Figure BDA0003377046150000081
In the method, the ultra-pure water is used for cleaning the HiPrep containing desalting columnTM26/10 desaling-containing protein purification system
Figure BDA0003377046150000082
(3) Filtering the crude exopolysaccharide solution from which the protein is removed by using a 0.22 mu m filter membrane to obtain a filtered crude exopolysaccharide solution, and sampling 7mL of the filtered crude exopolysaccharide solution onto a desalting column at the flow rate of 10mL/min each time;
(4) according to UV490Respectively starting and ending the peak value and the peak position of the salt peak, and collecting samples flowing out of the desalting column to obtain a desalting chromatographic solution;
(5) finally, the protein purification system is cleaned by sequentially utilizing ultrapure water and 20% (v/v) ethanol
Figure BDA0003377046150000083
And desalting column HiPrepTM 26/10 Desalting;
(6) The content of the extracellular polysaccharide in the desalted chromatographic solution is accurately detected by using a phenol-sulfuric acid method, and the concentration is about 20 mg/mL.
1.3 anion exchange chromatography
The anion exchange chromatography Column used was a 5mL HiTrap Q HP Column (Q-HP), and the purification procedure for the desalted chromatography solution was as follows:
(1) installing an anion exchange chromatography column Q-HP in a protein purification system
Figure BDA0003377046150000084
Protein purification system cleaned by ultrapure water
Figure BDA0003377046150000085
At the same time, 2.0mol/L sodium chloride water solution is used for balancing the anion exchange chromatographic column Q-HP;
(2) according to the concentration of exopolysaccharide in the desalted chromatography liquid measured by phenol-sulfuric acid method (making the concentration between 10-15 mg/mL), a protein purification system is used
Figure BDA0003377046150000086
The S1 sample pump is used for loading the desalted chromatographic solution to the anion exchange chromatographic column Q-HP, the sample loading amount is 15-20mL each time, the flow rate is 2.0mL/min, and meanwhile, a 96-hole deep-hole plate is used for manual collection, namely 1.7 mL/tube;
(3) after the sample loading is finished, washing the anion exchange chromatography column Q-HP by using ultrapure water with 5 times of column volume;
(4) linearly eluting with 2mol/L sodium chloride water solution at concentration of 0-100% for 20min at flow rate of 5mL/min to obtain eluate;
(5) finally, respectively cleaning the protein purification system by sequentially utilizing ultrapure water and 20% ethanol
Figure BDA0003377046150000091
And an anion exchange chromatography column Q-HP;
(6) after the collection, detecting the hole position of the extracellular polysaccharide-containing eluent by using a phenol-sulfuric acid method (see figure 1), wherein the result shows that the single polysaccharide absorption peak appears, the salt ion concentration of the single polysaccharide absorption peak is between 5 and 10 percent, mixing the extracellular polysaccharide-containing hole position eluents, and concentrating the mixed eluents to 1/10 (about 30mL) of the original volume by using a freeze dryer to obtain the ion chromatography liquid.
1.4 gel filtration chromatography
The gel filtration chromatography column HiLoad 26/600 Sephacryl S-100column (Sephacryl S-100column, GE Healthcare Life Sciences) was used, and the purification procedure for the ion chromatography liquid was as follows:
(1) installing gel filtration chromatography column HiLoad 26/600 Seperdex 200 prep grade column in protein purification system
Figure BDA0003377046150000092
In the middle, 0.15mol/L sodium chloride aqueous solution is used for cleaning the protein purification system
Figure BDA0003377046150000093
And a gel filtration chromatography column;
(2) taking 5mL of ion chromatography liquid each time, manually loading the sample to a gel filtration chromatography column, immediately collecting the sample, wherein the flow rate of the system is 0.5mL/min, collecting by using a 96-well plate, collecting 0.5mL of ion chromatography liquid in each well, collecting 180mL (namely 1.5 column volumes) in total, and stopping collecting to obtain gel chromatography liquid;
(3) finally, respectively cleaning the protein purification system and the gel filtration chromatographic column by sequentially utilizing ultrapure water and 20% ethanol;
(4) detecting the hole position of the gel chromatographic solution containing the extracellular polysaccharide by using a phenol-sulfuric acid method (see figure 2), wherein the result shows that the gel chromatographic solution is a single absorption peak, and combining the gel chromatographic solutions of the extracellular polysaccharide at the hole position of the single absorption peak to obtain the pure extracellular polysaccharide. And according to OD490nmAbsorbance values elution curves were plotted and single major peak positions were collected and either freeze-concentrated to 1/10 in bulk or freeze-dried to powder.
2 determination of molecular weight
And (3) determining the total sugar content, the protein content, the reducing sugar content and the uronic acid content of the pure extracellular polysaccharide obtained after gel filtration chromatography. The measurement method and the results are shown in Table 1:
TABLE 1
Figure BDA0003377046150000094
The results from table 1 show that the total sugar content of the purified exopolysaccharide purified from IPPBiotSR045 is 96.31%, and the uronic acid, protein and reducing sugar contents are all low, 1.38%, 0.13% and 2.18%, respectively. The full wavelength scan showed that the absorbance at 260nm and 280nm was less than 0.1 (fig. 3), i.e. the pure exopolysaccharide contained almost no nucleic acids and proteins, further indicating the high purity of the exopolysaccharide sample.
Molecular weight analysis Gel exclusion chromatography column Ohpak SB-805HQ (300X 8mm), Ohpak SB-804HQ (300X 8mm) and Ohpak SB-803HQ (300X 8mm) were connected in series according to the molecular weight of the extracellular polysaccharide preliminarily judged by the purification step, to obtain a series column, using a Gel chromatography-differential-multiangle laser light scattering system (GPC-RI-MALS), wherein the laser light scattering detector was DAWN HELEOS II (Wyatt technology, CA, USA), and the differential detector was Optilab T-rEX (Wyatt technology, CA, USA). The specific experimental procedures are as follows:
(1) accurately weighing extracellular polysaccharide powder 10.0mg after gel filtration chromatography and freeze drying, and dissolving in 1.0mL of 0.1mol/L NaNO3In the water solution, then 14000r/min, centrifuging for 10min to obtain supernatant;
(2) filtering the supernatant with 0.22 μm filter membrane to load the serial column;
(3) the sample loading amount to the series column is 100 mu L in one time, and the mobile phase is 0.1mol/L NaNO3The flow rate is 0.4mL/min, and the column temperature is kept at 45 ℃;
(4) data were collected and analyzed using ASTR6.1(Wyatt technology corporation, USA) software.
The results show that: the extracellular polysaccharide has Mw of 66.2kDa, Mn of 42.7kDa and Mz of 87.6 kDa. The Polydispersity (Mw/Mn) is 1.55. In addition, the change trend of the multi-angle laser light scattering signal is completely consistent with that of the differential signal, which indicates that the molecular weight analysis of the extracellular polysaccharide is more accurate and indicates that the extracellular polysaccharide is single-component homogeneous polysaccharide.
3 analysis of monosaccharide composition
The monosaccharide composition analysis adopts a Thermo-ion exchange chromatography system (High-performance and-exchange chromatography, model ICS5000+, USA), and the liquid chromatography column is DionexTMCarboPacTMPA10(250 × 4.0mm, 10 μm), the specific experimental procedure was as follows:
(1) preparing a standard substance: preparing to weigh 100mg of different monosaccharide standards, which comprise: glucose, rhamnose, arabinose, galactose, xylose, mannose, fructose and glucuronic acid;
(2) drawing a standard curve: diluting the standard substance into 1, 10, 20, 30, 40 and 50 mu g/mL aqueous solution respectively, wherein the loading amount is 20 mu L, the A mobile phase is water, the B mobile phase is 100mM NaOH, the column temperature is kept at 30 ℃, and a curve is drawn according to the retention time and the peak height of each component in the system;
(3) weighing 5mg (+ -0.05 mg) of extracellular polysaccharide powder subjected to gel filtration chromatography and freeze drying, adding trifluoroacetic acid, hydrolyzing at 121 ℃ for 2h, blow-drying with nitrogen, then cleaning with methanol, blow-drying again, and repeating methanol cleaning-blow-drying for 2-3 times. Adding sterile water to dissolve to be detected;
(4) comparing the retention time of the exopolysaccharide with the retention time of the standard monosaccharide to determine the monosaccharide composition of the exopolysaccharide.
The monosaccharide composition analysis results of exopolysaccharides are shown in fig. 4, the retention time of each component in exopolysaccharides is compared with that of a standard sample, and the monosaccharide components of exopolysaccharides are mainly mannose, glucuronic acid, glucose and galactose, and the relative molar ratio of the monosaccharide components to the monosaccharides is 55.77: 5.67: 3.70: 1. thus, exopolysaccharide is a heteropolysaccharide.
Example 3
Respectively dissolving 40 micrograms and 80 micrograms of purified exopolysaccharide in 1mL of sterile water to obtain exopolysaccharide aqueous solution, spraying the exopolysaccharide aqueous solution on the soil surface near the roots of the rapes by 40 micrograms/strain and 80 micrograms/strain, and taking the sterile water as a control group. Three biological replicates per treatment. The sclerotinia sclerotiorum cake was inoculated to rape leaves 5 days after the rape roots were treated with exopolysaccharide or sterile water, and the spread of the disease was observed on the 0 th, 2 th, 5 th and 7 th days of the inoculation, and the spread of the disease of the leaves after the rape roots were treated with exopolysaccharide 40. mu.g/strain and sterile water is shown in FIG. 5. According to the figure 5, after 7 days of exopolysaccharide treatment, the growth state of the rape is good, the leaf spots are not enlarged, the rape leaf spots after sterile water treatment rapidly spread two days after receiving diseases, and the leaf curling phenomenon appears 7 days. The lesion diameter of rape leaves after being inoculated with sclerotinia sclerotiorum for 7 days after being treated by 40 mu g/strain and 80 mu g/strain of exopolysaccharide is measured, and the induced disease-resistant effect is calculated by a formula of (lesion diameter of a control group-lesion diameter of an experimental group)/lesion diameter of the control group multiplied by 100 percent, and the result is shown in table 2. LSD analysis shows that the two groups of extracellular polysaccharide treatment groups have significant difference with the control group, and the difference is more than 50%. In conclusion, the purified extracellular polysaccharide of the IPPBiotSR045 strain has obvious disease resistance induction capability.
TABLE 2 statistical results of the lesion diameter of rape leaves when inoculating sclerotinia sclerotiorum after EPS treatment
Figure BDA0003377046150000111
Note: each set of data represents the mean ± standard error of the three sets of duplicate data; lower case letters in the graph indicate significant differences at the p <0.05 level for one-way ANOVA analysis between treatments.
Example 4
Fluorescence quantitative PCR standard curve:
respectively amplifying an internal reference gene actin (using act35F and act143R primers, wherein the nucleotide sequence of act35F is shown as SEQ ID No.1, and the nucleotide sequence of act143R is shown as SEQ ID No. 2) and a salicylic acid signal path related gene BnWRKY70 (using wrk592F and wrk693R primers for amplification, wherein the nucleotide sequence of wrk592F is shown as SEQ ID No.3, the nucleotide sequence of wrk693R is shown as SEQ ID No. 4), a jasmonic acid signal path related gene BnHEL (using hel431R and hel549R primers for amplification, wherein the nucleotide sequence of hel431R is shown as SEQ ID No.5, and the nucleotide sequence of hel549R is shown as SEQ ID No. 6) by taking a rape genome as a template, and amplifying the internal reference gene actin, wherein the nucleotide sequence of act35 and the nucleotide sequence of the hel549R are shown as SEQ ID No.6 respectively, jasmonic acid and ethylene signal pathway related gene BnPDFF 1.2 (amplified by using pdf10F and pdf107R primers, wherein the nucleotide sequence of pdf10F is shown as SEQ ID No.7, and the nucleotide sequence of pdf107R is shown as SEQ ID No. 8.) was enriched and purified by 10 cycles of ordinary PCR amplification. And diluting the enriched and purified product in a gradient manner and then using the diluted product as a template for drawing a fluorescent quantitative PCR standard curve. The reaction system and conditions refer to the instructions of a SuperReal PreMix Plus (SYBR Green) kit, and the reference gene and the target gene are drawn into a double-standard curve and subjected to related gene transcription level analysis. And when the R value of the standard curve of the gene is more than 0.99, the requirement of subsequent experiments can be met.
Dissolving 40 mu g of exopolysaccharide in 1mL of sterile water to obtain an exopolysaccharide aqueous solution, spraying 40 mu g of exopolysaccharide per strain on the soil surface near the rape roots, and taking the sterile water as a control group. After the roots of the rapes are treated by exopolysaccharides or sterile water for 5 days, respectively taking rape leaves 0 day, 2 days, 5 days and 7 days after the treatment, extracting total RNA of the rape leaves by using a Trizol method, synthesizing cDNA by using a Promega reverse transcription kit, analyzing the transcription conditions of BnHEL, BnWRKY70 and BnPDF1.2 genes in the rape leaves 0 day, 2 days, 5 days and 7 days after the exopolysaccharides are applied by using fluorescence quantitative PCR (qRT-PCR), and taking actin as an internal reference gene.
The transcription conditions of the gene BnWRKY70 related to the salicylic acid signal pathway, the gene BnHEL related to the jasmonic acid signal pathway and the gene BnPDF1.2 related to the jasmonic acid and ethylene signal pathway after the roots of the rape are treated with the exopolysaccharide for 0 day, 2 days, 5 days and 7 days are shown in FIGS. 6 to 8. All data in the figure are mean ± standard error of three sets of duplicate data. And LSD in the one-way variance ANOVA is used for carrying out statistical analysis, and the result shows that the transcription level of the BnWRKY70 gene is basically unchanged after the rape roots are treated by the extracellular polysaccharide, and has no significant difference (p is more than 0.05) with the transcription level of the day 0; the BnHEL gene started up-regulated transcription 5 days after exopolysaccharide treatment (p ═ 0.1990), with more pronounced up-regulation at day 7 (p ═ 0.009), which was 1.63 and 2.96 times the relative transcription level at day 0, respectively; the bnpdf1.2 gene was up-regulated at day 2 after exopolysaccharide treatment (p 0.102), and at day 7, the transcript level was significantly different from that at day 0 (p 0.005), which was 2.22 times that at day 0. In summary, the jasmonic acid and ethylene signaling pathways were activated after treatment of canola roots with exopolysaccharides.
While the invention has been described with reference to specific embodiments, those skilled in the art will appreciate that various changes can be made without departing from the true spirit and scope of the invention. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, and method to the essential scope and spirit of the present invention. All such modifications are intended to be included within the scope of the present invention as defined in the appended claims.
Sequence listing
<110> institute of plant protection of Chinese academy of agricultural sciences
<120> an exopolysaccharide extract, exopolysaccharide and uses thereof
<130> LHA2160512
<160> 8
<170> SIPOSequenceListing 1.0
<210> 1
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
gtgccgatct acgaaggtta tg 22
<210> 2
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
gtaccctctc tcggtgagaa t 21
<210> 3
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
aagcaagtgc agaagctaga g 21
<210> 4
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
ggcttgatct tgggtgatac tt 22
<210> 5
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
ggtgaggaac acaaggacta at 22
<210> 6
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
gccatcacca tcggtatcta tt 22
<210> 7
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
ttcctcacac accacacata c 21
<210> 8
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
acaagagcag cgaagagaag 20

Claims (10)

1.一种胞外多糖提取物,其通过如下步骤提取得到:1. An extracellular polysaccharide extract, which is extracted by the following steps: 一)将苏云金芽胞杆菌IPPBiotSR045的发酵液pH值调至8至9,然后进行第一离心,收集第一离心后的第一上清液;1) the pH value of the fermentation broth of Bacillus thuringiensis IPPBiotSR045 is adjusted to 8 to 9, then the first centrifugation is performed to collect the first supernatant after the first centrifugation; 二)在所述第一上清液中加入三氯乙酸或三氯乙酸的水溶液,从而用三氯乙酸处理所述第一上清液,得到第一处理液,然后进行第二离心,收集第二离心后的第二上清液;2) adding trichloroacetic acid or an aqueous solution of trichloroacetic acid to the first supernatant, thereby treating the first supernatant with trichloroacetic acid to obtain the first treatment solution, and then performing a second centrifugation to collect the first Second supernatant after centrifugation; 三)将所述第二上清液的pH值调至6至7后向所述第二上清液中加入乙醇,得到第二处理液,对所述第二处理液进行沉淀,然后进行第三离心,收集第三离心后的沉淀物,所述沉淀物即为湿的粗胞外多糖提取物。3) After the pH value of the second supernatant is adjusted to 6 to 7, ethanol is added to the second supernatant to obtain a second treatment solution, the second treatment solution is precipitated, and then the first treatment solution is carried out. The third centrifugation, the precipitate after the third centrifugation was collected, and the precipitate was the wet crude exopolysaccharide extract. 2.根据权利要求1所述的胞外多糖提取物,其特征在于,还包括对所述粗胞外多糖提取物依次进行去除残留蛋白、脱盐、离子交换层析和凝胶过滤层析的步骤;2. The extracellular polysaccharide extract according to claim 1, further comprising the steps of successively removing residual protein, desalting, ion exchange chromatography and gel filtration chromatography to the crude extracellular polysaccharide extract ; 优选地,利用蛋白酶K去除所述残留蛋白;Preferably, the residual protein is removed using proteinase K; 利用HiPrepTM26/10 Desalting脱盐柱对去除残留蛋白的粗胞外多糖提取物进行脱盐,得到脱盐层析液;The crude exopolysaccharide extract from which residual protein was removed was desalted by using a HiPrep TM 26/10 Desalting desalting column to obtain a desalted chromatographic solution; 利用HiTrap Q HP Column阴离子交换柱对脱盐层析液进行纯化,得到离子层析液;Utilize HiTrap Q HP Column anion exchange column to purify the desalting chromatographic liquid to obtain ionic chromatographic liquid; 利用HiLoad 26/600 Sephacryl S-100column凝胶过滤层柱对离子层析液进行纯化,得到多个孔位的凝胶层析液;Utilize HiLoad 26/600 Sephacryl S-100column gel filtration layer column to purify the ion chromatographic fluid to obtain gel chromatographic fluid with multiple pores; 将含有胞外多糖的孔位的凝胶层析液混合,利用冷冻干燥仪浓缩得到湿的纯胞外多糖提取物;或利用冷冻干燥仪干燥为粉末,得到干的纯胞外多糖提取物。The gel chromatography liquid containing the pores of the exopolysaccharide is mixed and concentrated by a freeze dryer to obtain a wet pure exopolysaccharide extract; or dried to a powder by a freeze dryer to obtain a dry pure exopolysaccharide extract. 3.根据权利要求2所述的胞外多糖提取物,其特征在于,利用HiPrepTM26/10 Desalting脱盐柱对去除残留蛋白的粗胞外多糖提取物进行脱盐包括如下步骤:3. exopolysaccharide extract according to claim 2, is characterized in that, utilizes HiPrep TM 26/10 Desalting desalting column to carry out desalting to the crude exopolysaccharide extract that removes residual protein and comprises the following steps: 1)将去除残留蛋白的粗胞外多糖提取物水溶液于10000r/min离心20min,以去除杂质;1) Centrifuge the crude exopolysaccharide extract aqueous solution with residual protein removed at 10000r/min for 20min to remove impurities; 2)将脱盐柱HiPrepTM26/10 Desalting装入蛋白纯化系统
Figure FDA0003377046140000011
中,用超纯水清洗包括脱盐柱HiPrepTM26/10 Desalting在内的蛋白纯化系统
Figure FDA0003377046140000012
2) Load the desalting column HiPrep TM 26/10 Desalting into the protein purification system
Figure FDA0003377046140000011
, wash the protein purification system including the desalting column HiPrep TM 26/10 Desalting with ultrapure water
Figure FDA0003377046140000012
3)用滤菌膜过滤所述去除残留蛋白的粗胞外多糖提取物水溶液,得到过滤后的提取物水溶液,每次取7mL过滤后的提取物水溶液以10mL/min的流速向脱盐柱上样;3) filter the described crude exopolysaccharide extract aqueous solution for removing residual protein with a bacterial filter membrane to obtain the filtered aqueous extract solution, and take 7 mL of the filtered aqueous extract solution each time and load the sample onto the desalting column at a flow rate of 10 mL/min ; 4)根据UV490的峰值以及盐峰的出峰位置分别开始和结束收集从所述脱盐柱流出的样品,得到脱盐层析液;4) according to the peak value of UV 490 and the peak position of the salt peak, respectively start and end to collect the samples flowing out from the desalting column to obtain the desalting chromatographic solution; 利用HiTrap Q HP Column阴离子交换柱对脱盐层析液进行纯化包括如下步骤:Purification of desalted chromatographic fluid using HiTrap Q HP Column anion exchange column includes the following steps: I)将所述阴离子交换柱安装于蛋白纯化系统
Figure FDA0003377046140000013
上,利用超纯水清洗蛋白纯化系统
Figure FDA0003377046140000021
同时用2mol/L氯化钠水溶液平衡阴离子交换柱;
1) Install the anion exchange column in a protein purification system
Figure FDA0003377046140000013
, using ultrapure water to clean the protein purification system
Figure FDA0003377046140000021
Equilibrate the anion exchange column with 2mol/L sodium chloride aqueous solution at the same time;
II)使所述脱盐层析液中的胞外多糖的浓度处于10至15mg/mL之后,利用S1上样泵对脱盐层析液向阴离子交换柱进行上样,每次上样量为15-20mL,流速为2.0mL/min,同时利用96孔深孔板手动收集,1.7mL/管;II) After the concentration of the exopolysaccharide in the desalting chromatographic solution is in the range of 10 to 15 mg/mL, the desalting chromatographic solution is loaded onto the anion exchange column using the S1 loading pump, and the amount of each loading is 15-15 mg/mL. 20mL, the flow rate is 2.0mL/min, and the 96-well deep-well plate is used for manual collection, 1.7mL/tube; III)待上样结束,用5倍所述阴离子交换柱的柱体积的超纯水清洗所述阴离子交换柱;III) until the end of sample loading, wash the anion exchange column with ultrapure water that is 5 times the column volume of the anion exchange column; IV)利用2mol/L氯化钠水溶液进行浓度为0-100%线性洗脱,洗脱20min,流速为5mL/min,得到洗脱液;IV) utilizing 2mol/L sodium chloride aqueous solution to carry out concentration is 0-100% linear elution, elution 20min, flow velocity is 5mL/min, obtains eluent; V)利用苯酚-硫酸法检测含有胞外多糖的洗脱液所在的孔位,将含有胞外多糖的孔位的洗脱液混合,利用冷冻干燥仪浓缩,得到离子层析液;V) utilize the phenol-sulfuric acid method to detect the pore position of the eluent containing the exopolysaccharide, mix the eluent containing the pore position of the exopolysaccharide, and concentrate using a freeze dryer to obtain an ion chromatography solution; 利用HiLoad 26/600 Sephacryl S-100 column凝胶过滤层析柱对离子层析液进行纯化包括如下步骤:Purification of ion chromatography using HiLoad 26/600 Sephacryl S-100 column gel filtration chromatography includes the following steps: A)将所述凝胶过滤层析柱安装于蛋白纯化系统
Figure FDA0003377046140000022
上,用0.15mol/L氯化钠水溶液清洗蛋白纯化系统
Figure FDA0003377046140000023
以及凝胶过滤层析柱;
A) Install the gel filtration column in a protein purification system
Figure FDA0003377046140000022
On, wash the protein purification system with 0.15mol/L sodium chloride aqueous solution
Figure FDA0003377046140000023
and gel filtration columns;
B)每次取5mL离子层析液向凝胶过滤层析柱进行手动上样,并立即用96孔板收集从所述凝胶过滤层析柱流出的样品,系统流速为0.5mL/min,每孔收集0.5mL,共收集180mL后停止收集,得到凝胶层析液;B) Take 5mL of ion chromatography solution to manually load the gel filtration chromatography column each time, and immediately use a 96-well plate to collect the samples flowing out from the gel filtration chromatography column, and the system flow rate is 0.5mL/min, Collect 0.5mL per well, and stop collecting after a total of 180mL is collected to obtain gel chromatography liquid; C)利用苯酚-硫酸法检测含有胞外多糖的凝胶层析液所在孔位,将含有胞外多糖孔位的凝胶层析液混合;利用冷冻干燥仪浓缩得到湿的纯胞外多糖提取物;或利用冷冻干燥仪干燥为粉末,得到干的纯胞外多糖提取物。C) use the phenol-sulfuric acid method to detect the pore position of the gel chromatography liquid containing exopolysaccharide, mix the gel chromatography liquid containing the exopolysaccharide pore position; use a freeze dryer to concentrate to obtain wet pure exopolysaccharide extraction Or use freeze dryer to dry into powder to obtain dry pure extracellular polysaccharide extract.
4.根据权利要求1所述的胞外多糖提取物,其特征在于,在步骤2)中,所述三氯乙酸与所述第一上清液的质量/体积含量为0.4%至0.5%;和/或4. The extracellular polysaccharide extract according to claim 1, wherein in step 2), the mass/volume content of the trichloroacetic acid and the first supernatant is 0.4% to 0.5%; and / or 在步骤3)中,向所述第二上清液中加入的乙醇的体积为所述第二上清液的体积的3至3.5倍。In step 3), the volume of ethanol added to the second supernatant is 3 to 3.5 times the volume of the second supernatant. 5.根据权利要求1所述的胞外多糖提取物,其特征在于,在步骤2)中,所述第一处理液于25至35℃的温度下放置1.5至3个小时;和/或5. The extracellular polysaccharide extract according to claim 1, wherein in step 2), the first treatment solution is placed at a temperature of 25 to 35°C for 1.5 to 3 hours; and/or 在步骤3)中,所述第二处理液于2至8℃放置12至20个小时。In step 3), the second treatment solution is placed at 2 to 8° C. for 12 to 20 hours. 6.根据权利要求1所述的胞外多糖提取物,其特征在于,所述第一离心、所述第二离心、所述第三离心的离心速度独立地为6000至8000r/min,离心温度独立地为3至10℃,离心时间独立地为30至40min。6. The extracellular polysaccharide extract according to claim 1, wherein the centrifugal speeds of the first centrifugation, the second centrifugation, and the third centrifugation are independently 6000 to 8000 r/min, and the centrifugation temperature Independently 3 to 10°C, and centrifugation time independently 30 to 40 min. 7.根据权利要求1所述的胞外多糖提取物,其特征在于,培养所述苏云金芽胞杆菌的培养基为LB培养基、以葡萄糖为底物的产糖培养基和以蔗糖为底物的产糖培养基中的一种。7. extracellular polysaccharide extract according to claim 1, is characterized in that, the substratum that cultivates described bacillus thuringiensis is LB substratum, the sugar-producing substratum that takes glucose as substrate and the substratum that takes sucrose as substrate One of the sugar-producing media. 8.根据权利要求1和4至7中任意一项所述的胞外多糖提取物,其特征在于,将所述沉淀物进行冷冻干燥,从而得到干的粗胞外多糖提取物。8. The exopolysaccharide extract according to any one of claims 1 and 4 to 7, wherein the precipitate is freeze-dried to obtain a dry crude exopolysaccharide extract. 9.一种胞外多糖,其Mw=66.2kDa,Mn=42.7kDa,Mz=87.6kDa,多分散度为1.55,所述胞外多糖由甘露糖、葡萄糖醛酸、葡萄糖和半乳糖组成,其中,所述甘露糖、所述葡萄糖醛酸、所述葡萄糖和所述半乳糖的相对摩尔比为55.77:5.67:3.70:1。9. An exopolysaccharide having Mw=66.2kDa, Mn=42.7kDa, Mz=87.6kDa, and a polydispersity of 1.55, said exopolysaccharide consisting of mannose, glucuronic acid, glucose and galactose, wherein , the relative molar ratio of the mannose, the glucuronic acid, the glucose and the galactose is 55.77:5.67:3.70:1. 10.根据权利要求1至8中任意一项所述的提取物或权利要求9中所述的胞外多糖在诱导植物抗病性中的应用;10. Use of the extract according to any one of claims 1 to 8 or the exopolysaccharide described in claim 9 in inducing plant disease resistance; 优选地,所述植物为油菜;Preferably, the plant is rape; 优选地,所述抗病性为抗核盘菌引起的病害。Preferably, the disease resistance is resistance to diseases caused by Sclerotinia sclerotiorum.
CN202111422635.7A 2021-11-26 2021-11-26 A kind of extracellular polysaccharide extract, extracellular polysaccharide and application thereof Pending CN114230681A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111422635.7A CN114230681A (en) 2021-11-26 2021-11-26 A kind of extracellular polysaccharide extract, extracellular polysaccharide and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111422635.7A CN114230681A (en) 2021-11-26 2021-11-26 A kind of extracellular polysaccharide extract, extracellular polysaccharide and application thereof

Publications (1)

Publication Number Publication Date
CN114230681A true CN114230681A (en) 2022-03-25

Family

ID=80751424

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111422635.7A Pending CN114230681A (en) 2021-11-26 2021-11-26 A kind of extracellular polysaccharide extract, extracellular polysaccharide and application thereof

Country Status (1)

Country Link
CN (1) CN114230681A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116590373A (en) * 2023-06-29 2023-08-15 广东海洋大学 A kind of exopolysaccharide of fermented Lactobacillus mucus, preparation method and application
CN118360180A (en) * 2023-12-27 2024-07-19 盐城师范学院 Klebsiella YCTU3162, extracellular polysaccharide Flocan produced by same and application thereof
CN119856718A (en) * 2025-03-25 2025-04-22 中国农业科学院植物保护研究所 Application of exopolysaccharide or extract containing exopolysaccharide in improving sunlight or ultraviolet degradation resistance of insecticidal protein

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2567722A1 (en) * 2004-05-27 2005-12-08 Novozymes Biopolymer A/S A dried and agglomerated hyaluronic acid product
CN105007741A (en) * 2012-12-03 2015-10-28 拜耳作物科学股份公司 Composition comprising a biological control agent and a fungicide
AU2015263304A1 (en) * 2014-05-23 2016-12-22 Basf Se Mixtures comprising a bacillus strain and a pesticide
CN106432530A (en) * 2016-11-24 2017-02-22 福建省农业科学院土壤肥料研究所 Extracting technology of dictyophora indusiata volva colloid polysaccharide
CN107058172A (en) * 2017-02-27 2017-08-18 中国农业科学院植物保护研究所 A kind of bacillus thuringiensis and its application
US20180092363A1 (en) * 2016-10-05 2018-04-05 Fmc Corporation Bacillus thuringiensis rti545 compositions and methods of use for benefiting plant growth and controlling plant pests
CN110089526A (en) * 2019-04-24 2019-08-06 中国农业科学院植物保护研究所 Plant polyose is promoting application and composition in thuringiensis prevention and treatment insect
CN112608871A (en) * 2021-01-12 2021-04-06 江南大学 Method for producing probiotic active substances by high-density fermentation of bacillus thuringiensis
CN113402626A (en) * 2021-07-12 2021-09-17 中国科学院华南植物园 Nymphaea hybrid polysaccharide extract and preparation method and application thereof

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2567722A1 (en) * 2004-05-27 2005-12-08 Novozymes Biopolymer A/S A dried and agglomerated hyaluronic acid product
CN105007741A (en) * 2012-12-03 2015-10-28 拜耳作物科学股份公司 Composition comprising a biological control agent and a fungicide
AU2015263304A1 (en) * 2014-05-23 2016-12-22 Basf Se Mixtures comprising a bacillus strain and a pesticide
US20180092363A1 (en) * 2016-10-05 2018-04-05 Fmc Corporation Bacillus thuringiensis rti545 compositions and methods of use for benefiting plant growth and controlling plant pests
CN106432530A (en) * 2016-11-24 2017-02-22 福建省农业科学院土壤肥料研究所 Extracting technology of dictyophora indusiata volva colloid polysaccharide
CN107058172A (en) * 2017-02-27 2017-08-18 中国农业科学院植物保护研究所 A kind of bacillus thuringiensis and its application
CN110089526A (en) * 2019-04-24 2019-08-06 中国农业科学院植物保护研究所 Plant polyose is promoting application and composition in thuringiensis prevention and treatment insect
CN112608871A (en) * 2021-01-12 2021-04-06 江南大学 Method for producing probiotic active substances by high-density fermentation of bacillus thuringiensis
CN113402626A (en) * 2021-07-12 2021-09-17 中国科学院华南植物园 Nymphaea hybrid polysaccharide extract and preparation method and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MEILING WANG ET AL.: ""Screening of Bacillus thuringiensis strains to identify new potential biocontrol agents against Sclerotinia sclerotiorum and Plutella xylostella in Brassica campestris L."", 《BIOLOGICAL CONTROL》 *
MEILING WANG ET AL.: ""Structure characteristics and function of a novel extracellular polysaccharide from Bacillus thuringiensis strain 4D19"", 《INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES》 *
王美玲: ""苏云金芽胞杆菌诱导油菜抗菌核病的研究"", 《中国优秀博硕士学位论文全文数据库(硕士)农业科技辑》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116590373A (en) * 2023-06-29 2023-08-15 广东海洋大学 A kind of exopolysaccharide of fermented Lactobacillus mucus, preparation method and application
CN116590373B (en) * 2023-06-29 2023-11-17 广东海洋大学 Fermented lactobacillus mucilaginosus extracellular polysaccharide, preparation method and application
CN118360180A (en) * 2023-12-27 2024-07-19 盐城师范学院 Klebsiella YCTU3162, extracellular polysaccharide Flocan produced by same and application thereof
CN119856718A (en) * 2025-03-25 2025-04-22 中国农业科学院植物保护研究所 Application of exopolysaccharide or extract containing exopolysaccharide in improving sunlight or ultraviolet degradation resistance of insecticidal protein

Similar Documents

Publication Publication Date Title
CN114230681A (en) A kind of extracellular polysaccharide extract, extracellular polysaccharide and application thereof
CN113564069B (en) Bifidobacterium longum, extracellular polysaccharide of bifidobacterium longum, and extraction method and application thereof
CN106755188A (en) The preparation method and brown alga oligose of a kind of brown alga oligose monomer
CN111440885B (en) Molecular marker for identifying sanzan glue and synthetic bacteria thereof, and preparation and application thereof
CN109182486B (en) Primer of molecular marker for identifying sanzan gum, gellan gum and welan gum, molecular marker and application
CN104232548B (en) Exopolysaccharide generated by pseudomonas, culture method and application
Sullivan et al. Characterization and poly (adenylic acid) content of Ehrlich ascites cell ribonucleic acids fractionated on unmodified cellulose columns
CN1178693C (en) A kind of preparation method of earthworm antimicrobial peptide
CN113151050A (en) A strain of Sphingomonas and its application
CN118978610A (en) Extract containing extracellular polysaccharide, extracellular polysaccharide and composition
CN100475971C (en) A kind of preparation method of exopolysaccharide of deep-sea cold suitable microorganism
CN111893150A (en) A kind of sucrose-induced bacterial solid-state fermentation to produce kola acid and purification method
CN113817078B (en) Poplar yellow fungus polysaccharide with anti-colorectal cancer effect based on immune regulation and control and application thereof
CN104651284B (en) Sphingol single-cell T 3 and its method for common fermentation production biological polyoses and poly- β hydroxybutyric acids
CN104231106B (en) Paenibacillus exopolysaccharide and preparation method and application of paenibacillus exopolysaccharide
CN110106121A (en) A kind of lactobacillus plantarum of extracellular polysaccharide
CN113265337A (en) Marine aspergillus versicolor and isolated culture method and application thereof
CN102154405B (en) Preparation method of hyaluronic acid
Fedonenko et al. Involvement of the lipopolysaccharides of Azospirilla in the interaction with wheat seedling roots
Morris et al. Possible biological roles for Rhizobium leguminosarum extracellular polysaccharide and cyclic glucans in bacteria-plant interactions for nitrogen-fixing bacteria
CN113956372B (en) Molecular marker and application of a kind of high acyl trizan gum and its production strain
CN108060187B (en) A kind of polysaccharide and its preparation method and application
CN114958989B (en) Treatment fluid, amplification system and kit for rapid and direct double PCR amplification
CN106011197A (en) Microorganism-derived algin and preparation and application thereof
Jindal et al. Isolation of microbial polysaccharides

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20220325